Compared with other breast cancer subtypes, TNBC is characterized by early relapse and aggressive behavior, with HER2-positive metastatic breast cancer specifically considered an incurable disease with the worst prognosis (Omarini et al., 2018). The gene discussed is ERBB2; the disease is breast cancer.